US 4,229,452 AGranted

Treatment of inflammatory disorders with 4-trifluoromethylimidazo[1,2-a]quinoxaline

AssigneeWestwood Pharmaceuticals, Inc.

InventorsPaul L. Warner, Jr., Edward J. Luber, Jr.

Life of this patent

Estimating the term…

Abstract

A method for treating inflammatory disorders in mammals which comprises administering to said mammals having an inflammatory disorder a therapeutically effective amount of 4-trifluoromethylimidazo[1,2-a]quinoxaline.

Claims7

Dependent claims

A method for treating inflammatory disorders in mammals which comprises administering to a mammal having an inflammatory disorder a therapeutically effective amount of 4-trifluoromethylimidazo[1,2-a]quinoxaline in combination with a pharmaceutically acceptable carrier therefor.

Dependencies are inferred from the claim text.

Facts

Application: 06/056,768Filed 12 Jul 1979 · continuation in part
Priority: 7 Jan 1977
Granted: 21 Oct 1980
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07D 231/12
Having two or three double bonds between ring members or between ring members and non-ring members: with only hydrogen atoms, hydrocarbon or…
C07D 233/56
Having two double bonds between ring members or between ring members and non-ring members: with only hydrogen atoms or radicals containing only…
C07D 249/08
Not condensed with other rings: 1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
C07D 487/04
In which the condensed system contains two hetero rings: ortho-condensed systems

Family

Serial757,640Parent of this continuation-in-part · filed 7 Jan 1977
Serial858,511Parent of this continuation-in-part · filed 8 Dec 1977
US 4,229,452 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results